Drug Type Synthetic peptide |
Synonyms LP 101, TZP-101 |
Target |
Mechanism GHSR agonists(Ghrelin/growth hormone secretagogue receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H39FN4O4 |
InChIKeyWGYPAJVJMXQXTR-ABNZCKJZSA-N |
CAS Registry842131-33-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Ulimorelin | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Postoperative ileus | Phase 3 | - | 01 Feb 2012 | |
Digestive System Disorders | Phase 1 | SK | 01 Jun 2011 | |
Digestive System Disorders | Phase 1 | GB | 01 Jun 2011 |
Phase 2 | 120 | wewfbxcflm(aqjsozpawp) = dqlklbmcau slwkvslplo (fmmtsaqvkw ) View more | Positive | 01 May 2019 | |||
wewfbxcflm(aqjsozpawp) = yrpwfsnalj slwkvslplo (fmmtsaqvkw ) View more |